Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of VX-702 with Methotrexate in Rheumatoid Arthritis
2006-004715-22Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vx-702 in rheumatoid arthritis (RA) (4 arms), sponsored by Vertex Pharmaceuticals. Primary endpoint: Biomarker response. Started Oct 2006; status: completed.
02
Drugs
vx-702
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-004715-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004715-22.